Business Trends

Jun 07, 2018
By BioPharm International Editors
A new report released at the BIO International Convention shows that the US bioscience industry has had a $2-trillion economic impact and has accelerated venture capital investment and job growth.
Jun 01, 2018
BioPharm International
By minding gaps in industry knowledge, bio/pharma companies can avoid development pitfalls.
Jun 01, 2018
By BioPharm International Editors
Madison Dearborn Partners will acquire a majority ownership position in CDMO Alcami.
Jun 01, 2018
By BioPharm International Editors
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
May 14, 2018
By BioPharm International Editors
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
May 09, 2018
By BioPharm International Editors
Takeda expands its global and therapy base with announced acquisition of Shire.
May 07, 2018
Smaller review divisions will bring experts closer to decision processes and reduce bottlenecks, FDA leaders say.
May 01, 2018
BioPharm International
While technology promises advances for healthcare, a skilled workforce is needed to deliver on the potential.
Apr 19, 2018
By BioPharm International Editors
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Apr 19, 2018
By BioPharm International Editors
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.
native1_300x100
lorem ipsum